GMP-Compliant Formulation Development: From Lab Scale to Clinical Batches
Bridging the gap between laboratory-scale pharmaceutical formulation and GMP-compliant clinical batch production presents significant technical challenges. KV LAB d.o.o. outlines the key considerations in scale-up design, excipient compatibility studies and process validation documentation that underpin successful regulatory submissions. Our formulation scientists work under EU GMP guidelines to deliver consistent, safe and efficacious dosage forms across oral solid, semi-solid and parenteral product categories.
Scale-Up Design Principles
At KV LAB d.o.o. we apply rigorous scientific methodology and state-of-the-art equipment to deliver reliable results that meet international regulatory standards.
- Excipient compatibility screening
- Critical quality attribute (CQA) mapping
- Process parameter risk assessment (FMEA)
Process Validation and Regulatory Documentation
Successful transfer from development to GMP manufacturing requires comprehensive process validation protocols aligned with FDA and EMA expectations. This includes installation qualification (IQ), operational qualification (OQ) and performance qualification (PQ) of manufacturing equipment, alongside thorough batch record documentation and change control procedures.
KV LAB d.o.o. remains committed to advancing pharmaceutical science through continuous investment in research infrastructure, expert personnel and international collaboration. Our teams follow ICH, EMA and ISO guidelines throughout every stage of the scientific process.
Leave a Comment